Intercept failed NASH candidate precipitated Alfasigma acquisition Markets September 30, 2023 [ad_1] Mohammed Haneefa Nizamudeen After the failure of Intercept Prescribed drugs’ (ICPT) Ocaliva (obeticolic acid) for nonalcoholic steatohepatitis (NASH) in…
Episode #398: Adam Nash, Daffy – Why This Prominent Silicon Valley Operator & Investor Wants To Make Charitable Giving A Habit – Meb Faber Research Finances March 20, 2022 [ad_1] Episode #398: Adam Nash, Daffy – Why This Distinguished Silicon Valley Operator & Investor Needs To Make Charitable Giving…
